1621326-36-0

Basic information

• Product Name: N-[3-(1-benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(3-fluorophenyl)acetamide
• Synonyms: N-[3-(1-benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(3-fluorophenyl)acetamide
• CAS NO: 1621326-36-0
• Molecular Weight: 386.385
• Mol File: 1621326-36-0.mol

Chemical Properties

• CAS DataBase Reference: N-[3-(1-benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(3-fluorophenyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[3-(1-benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(3-fluorophenyl)acetamide(1621326-36-0)
• EPA Substance Registry System: N-[3-(1-benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(3-fluorophenyl)acetamide(1621326-36-0)

Safety Data

• Hazardous Substances Data: 1621326-36-0(Hazardous Substances Data)

Upstream product

• 1414772-61-4 3-(1-benzofuran-2-yl)-6-chloroimidazo[1,2-b]pyridazine 
• 370-45-6 2-(3-fluorophenyl)acetamide 
• 13526-66-4 3-bromo-6-chloro-imidazo[1,2-b]pyridazine 
• 98437-24-2 benzofuran-2-boronic acid 

Relevant articles and documents

AMIDOIMIDAZOPYRIDAZINES AS MKNK-1 KINASE INHIBITORS

The present invention relates to amido-substituted imidazopyridazine compounds of general formula (I) : in which A, R1, R2, R3, R4 and n are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper- proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.